# Vertex Competitors

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Vertex Pharmaceutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Vertex Pharmaceutic in the context of predictive analytics.

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Vertex Pharmaceutic. Your research has to be compared to or analyzed against Vertex Pharmaceutic's peers to derive any actionable benefits. When done correctly, Vertex Pharmaceutic's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Vertex Pharmaceutic.

## Vertex Pharmaceutic Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Vertex Pharmaceutic and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Vertex and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Vertex Pharmaceutic does not affect the price movement of the other competitor.

PFE | PRGO | CMG | GOOGL | VLDR | IRBT | A | NCMI | AA | ||

PFE | 0.59 | 0.02 | 0.27 | -0.56 | -0.26 | 0.18 | -0.35 | -0.6 | PFE | |

PRGO | 0.59 | 0.67 | 0.65 | -0.16 | 0.44 | 0.73 | 0.4 | -0.15 | PRGO | |

CMG | 0.02 | 0.67 | 0.72 | 0.41 | 0.88 | 0.93 | 0.87 | 0.44 | CMG | |

GOOGL | 0.27 | 0.65 | 0.72 | 0.38 | 0.63 | 0.67 | 0.51 | 0.21 | GOOGL | |

VLDR | -0.56 | -0.16 | 0.41 | 0.38 | 0.64 | 0.26 | 0.57 | 0.74 | VLDR | |

IRBT | -0.26 | 0.44 | 0.88 | 0.63 | 0.64 | 0.76 | 0.85 | 0.61 | IRBT | |

A | 0.18 | 0.73 | 0.93 | 0.67 | 0.26 | 0.76 | 0.83 | 0.34 | A | |

NCMI | -0.35 | 0.4 | 0.87 | 0.51 | 0.57 | 0.85 | 0.83 | 0.6 | NCMI | |

AA | -0.6 | -0.15 | 0.44 | 0.21 | 0.74 | 0.61 | 0.34 | 0.6 | AA | |

PFE | PRGO | CMG | GOOGL | VLDR | IRBT | A | NCMI | AA |

Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |

## Vertex Pharmaceutic Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Vertex Pharmaceutic stock performing well and Vertex Pharmaceutic company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Vertex Pharmaceutic's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.MeanDeviation | JensenAlpha | SortinoRatio | TreynorRatio | SemiDeviation | InformationRatio | ExpectedShortfall | PotentialUpside | ValueAt Risk | MaximumDrawdown | ||

PFE | 1.31 | (0.11) | (0.07) | 0.03 | 1.69 | (0.08) | (1.29) | 3.00 | (2.35) | 6.72 | |

PRGO | 1.13 | 0.07 | 0.01 | 0.27 | 1.10 | 0.0129 | (1.37) | 2.23 | (2.04) | 6.42 | |

CMG | 2.05 | 0.31 | 0.17 | 0.36 | 2.09 | 0.13 | (2.53) | 4.28 | (3.67) | 16.34 | |

GOOGL | 1.96 | (0.06) | 0.03 | 0.13 | 2.12 | 0.0256 | (2.19) | 4.38 | (3.40) | 10.75 | |

VLDR | 5.28 | 0.44 | 0.11 | 0.30 | 6.18 | 0.1 | (5.81) | 8.93 | (9.52) | 34.49 | |

IRBT | 3.14 | 0.76 | 0.24 | 0.76 | 2.55 | 0.18 | (3.71) | 6.53 | (4.89) | 19.17 | |

A | 1.60 | 0.04 | 0.05 | 0.20 | 1.72 | 0.0414 | (1.85) | 3.43 | (3.13) | 8.86 | |

NCMI | 4.83 | 0.70 | 0.12 | 0.46 | 6.46 | 0.14 | (5.34) | 10.63 | (8.26) | 38.74 | |

AA | 2.61 | (0.24) | (0.03) | 0.02 | 3.49 | (0.0375) | (2.44) | 5.50 | (5.50) | 12.60 |

## Cross Equities Net Income Analysis

Compare Vertex Pharmaceutic and related stocks such as Pfizer Inc, Perrigo Company, Chipotle Mexican Grill, Alphabet Cl A, Velodyne Lidar, Irobot Corp, Agilent Technologies, National Cinemedia, and Alcoa Corp Net Income Over Time

Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |

PFE | 8.3 B | 10 B | 14.6 B | 22 B | 9.1 B | 7 B | 7.2 B | 21.3 B | 11.2 B | 16.3 B | 9.6 B | 22 B | 23.7 B |

CMG | 214.9 M | 214.9 M | 278 M | 327.4 M | 445.4 M | 475.6 M | 22.9 M | 176.3 M | 176.6 M | 350.2 M | 355.8 M | 653 M | 526.6 M |

GOOGL | 9.7 B | 9.7 B | 10.7 B | 12.7 B | 14.1 B | 16.3 B | 19.5 B | 12.7 B | 30.7 B | 34.3 B | 40.3 B | 76 B | 82 B |

IRBT | 30.4 M | 40.2 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 41.9 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 38.1 M |

A | 1 B | 1.2 B | 734 M | 549 M | 401 M | 462 M | 684 M | 316 M | 1.1 B | 719 M | 719 M | 647.1 M | 639.6 M |

NCMI | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 15.4 M | 36.1 M | 36.1 M | 36.1 M | (48.7 M) | (65.4 M) | (75.2 M) | (77.2 M) |

AA | (2.9 B) | (2.9 B) | (2.9 B) | (2.9 B) | (256 M) | (863 M) | (400 M) | 279 M | 250 M | (1.1 B) | (170 M) | 429 M | 462.9 M |

## Vertex Pharmaceutic and related stocks such as Pfizer Inc, Perrigo Company, Chipotle Mexican Grill, Alphabet Cl A, Velodyne Lidar, Irobot Corp, Agilent Technologies, National Cinemedia, and Alcoa Corp Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Vertex Pharmaceutic financial statement analysis. It represents the amount of money remaining after all of Vertex Pharmaceutic operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.## Vertex Pharmaceutic Competitive Analysis

The better you understand Vertex Pharmaceutic competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Vertex Pharmaceutic's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Vertex Pharmaceutic's competition over several years is one of the best ways to analyze its investment potential.Better Than Average | Worse Than Peers | View Performance Chart |

## Vertex Pharmaceutic Competition Performance Charts

## Complement your Vertex Pharmaceutic position

In addition to having Vertex Pharmaceutic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.## Did You Try This Idea?

### Run USD Crypto Fund Thematic Idea Now

##### USD Crypto Fund

Fund from digital currency traded on multiple global exchanges in US dollors. The USD Crypto Fund theme has 24 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize USD Crypto Fund Theme or any other thematic opportunities.

View All Next | Launch |

Also, please take a look at Vertex Pharmaceutic Correlation with its peers. Note that the Vertex Pharmaceutic information on this page should be used as a complementary analysis to other Vertex Pharmaceutic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

## Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceutic price analysis, check to measure Vertex Pharmaceutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceutic is operating at the current time. Most of Vertex Pharmaceutic's value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceutic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vertex Pharmaceutic's price. Additionally, you may evaluate how the addition of Vertex Pharmaceutic to your portfolios can decrease your overall portfolio volatility.

Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments | Go | |

Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | Go | |

Fund ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges | Go | |

Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. | Go | |

Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | Go | |

Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | Go | |

Price TransformationUse Price Transformation models to analyze depth of different equity instruments across global markets | Go | |

Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios | Go |

Is Vertex Pharmaceutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceutic. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth YOY 11.1 | Market Capitalization 75.5 B | Quarterly Revenue Growth YOY 0.23 | Return On Assets 0.14 | Return On Equity 0.3 |

The market value of Vertex Pharmaceutic is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceutic's value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceutic's market value can be influenced by many factors that don't directly affect Vertex Pharmaceutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vertex Pharmaceutic's value and its price as these two are different measures arrived at by different means. Investors typically determine Vertex Pharmaceutic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

VRTX | Stock | ## USD 294.52 2.36 0.81% |

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Vertex Pharmaceutic competition on your existing holdings. Also, please take a look at Vertex Pharmaceutic Correlation with its peers.

Vertex |

**B**in 2022, whereas Revenue to Assets are likely to drop 0.50 in 2022.